MagGenix Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Accelerator/Inc
- Latest Deal Amount
-
$10K
- Investors
-
3
MagGenix General Information
Description
Developer of a cellular engineering platform designed to control cell therapies using electromagnetic waves. The company's technology utilizes proprietary gene circuitry and over-the-air electromagnetic signals to enable precise spatiotemporal activation of biological systems, providing clinicians with the capability to concentrate therapeutic activity in specific locations and reduce off-target effects during treatment.
Contact Information
Website
www.maggenix.bioCorporate Office
- 1812 Ashland Avenue
- Baltimore, MD 21205
- United States
Corporate Office
- 1812 Ashland Avenue
- Baltimore, MD 21205
- United States
MagGenix Timeline
MagGenix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Accelerator/Incubator | 04-Nov-2023 | $10K | Completed | Generating Revenue | ||
| 2. Accelerator/Incubator | 07-Aug-2023 | Completed | Generating Revenue | |||
| 1. Grant | 01-Jan-2023 | $25K | Completed | Generating Revenue |
MagGenix Comparisons
Industry
Financing
Details
MagGenix Competitors (14)
One of MagGenix’s 14 competitors is Oxford Nanopore Technologies, a Formerly VC-backed company based in Oxford, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Oxford Nanopore Technologies | Formerly VC-backed | Oxford, United Kingdom | ||||
| Cytek Biosciences | Formerly VC-backed | Fremont, CA | ||||
| Vizgen | Venture Capital-Backed | Cambridge, MA | ||||
| ChromaCode | Venture Capital-Backed | Carlsbad, CA | ||||
| Preomics | Venture Capital-Backed | Munich, Germany |
MagGenix Patents
MagGenix Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025155744-A1 | Constructs and methods for regulation of a target molecule | Pending | 19-Jan-2024 |
MagGenix Signals
MagGenix Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| iGem Startups | Accelerator/Incubator | |||
| Johns Hopkins Technology Ventures | Accelerator/Incubator | |||
| Baylor New Venture Competition | Not-For-Profit Venture Capital |
MagGenix FAQs
-
When was MagGenix founded?
MagGenix was founded in 2021.
-
Where is MagGenix headquartered?
MagGenix is headquartered in Baltimore, MD.
-
What is the size of MagGenix?
MagGenix has 7 total employees.
-
What industry is MagGenix in?
MagGenix’s primary industry is Biotechnology.
-
Is MagGenix a private or public company?
MagGenix is a Private company.
-
What is MagGenix’s current revenue?
The current revenue for MagGenix is .
-
How much funding has MagGenix raised over time?
MagGenix has raised $20K.
-
Who are MagGenix’s investors?
iGem Startups, Johns Hopkins Technology Ventures, and Baylor New Venture Competition have invested in MagGenix.
-
Who are MagGenix’s competitors?
Oxford Nanopore Technologies, Cytek Biosciences, Vizgen, ChromaCode, and Preomics are some of the 14 competitors of MagGenix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process